Stocks
Bio-Rad Laboratories (BIO) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 191.2% | -160.2% | -24.5% | -83.5% | 48.4% | 1.34% | ||
| Changes by years, y/y, % | -8pp | -351pp | +136pp | -59pp | +132pp | -24.7% | |||
Bio-Rad Laboratories. EBITDA margin, %
Bio-Rad Laboratories. EBITDA margin, changes, pp
Bio-Rad Laboratories (BIO) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 22.8% | 73.2% | -55.8% | 143.3% | -107.5% | 1.34% | |
| Changes by years, y/y, % | -67pp | +500pp | -198pp | +270pp | -130pp | |||
| Changes by quarters, q/q, % | +150pp | +50pp | -129pp | +199pp | -251pp | |||
